These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38602300)

  • 21. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
    Przewratil P; Sitkiewicz A; Andrzejewska E
    Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol.
    Şen HS; Yalçın B; Canpınar H; Ocak S; Akyüz C
    Turk J Pediatr; 2020; 62(6):979-985. PubMed ID: 33372436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment.
    Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K
    Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical propranolol cream in treatment of superficial infantile hemangiomas: a literature review and 4 years of clinical experience.
    Kovačević M; Lukinović Škudar V; Maričić G; Krnjević-Pezić G; Stanimirović A
    Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(4):75-8. PubMed ID: 25527040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile hemangiomas, complications and treatments.
    Cheng CE; Friedlander SF
    Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.
    Thaivalappil S; Bauman N; Saieg A; Movius E; Brown KJ; Preciado D
    JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1026-31. PubMed ID: 24135743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells.
    Ma X; Zhao T; Ouyang T; Xin S; Ma Y; Chang M
    Int J Clin Exp Pathol; 2014; 7(7):3809-17. PubMed ID: 25120757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
    Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
    Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequelae following infantile haemangiomas treated with propranolol.
    Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
    Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Color Doppler Ultrasound Follow-Up of Infantile Hemangiomas and Peripheral Vascularity in Patients Treated with Propranolol.
    Kutz AM; Aranibar L; Lobos N; Wortsman X
    Pediatr Dermatol; 2015; 32(4):468-75. PubMed ID: 25940359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
    Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
    Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.
    Dong JY; Ning JX; Li K; Liu C; Wang XX; Li RH; Yue LL; Huang YY; Liu SH
    Sci Rep; 2017 Mar; 7(1):342. PubMed ID: 28336941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment.
    Wnęk A; Andrzejewska E; Kobos J; Taran K; Przewratil P
    Immunol Lett; 2017 May; 185():27-31. PubMed ID: 28279700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eczematous dermatitis in an infantile hemangioma with minimal or arrested growth.
    Roncone K; Kindley KJ; Zlotoff B
    Pediatr Dermatol; 2018 Mar; 35(2):261-262. PubMed ID: 29266347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile and congenital hemangiomas.
    Liang MG; Frieden IJ
    Semin Pediatr Surg; 2014 Aug; 23(4):162-7. PubMed ID: 25241092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
    Sondhi V; Patnaik SK
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.